GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (HKSE:06929) » Definitions » PE Ratio (TTM)

OrbusNeich Medical Group Holdings (HKSE:06929) PE Ratio (TTM) : 12.36 (As of Dec. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is OrbusNeich Medical Group Holdings PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-12), OrbusNeich Medical Group Holdings's share price is HK$4.50. OrbusNeich Medical Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.36. Therefore, OrbusNeich Medical Group Holdings's PE Ratio (TTM) for today is 12.36.


The historical rank and industry rank for OrbusNeich Medical Group Holdings's PE Ratio (TTM) or its related term are showing as below:

HKSE:06929' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 7.42   Med: 29.37   Max: 65.43
Current: 12.36


During the past 5 years, the highest PE Ratio (TTM) of OrbusNeich Medical Group Holdings was 65.43. The lowest was 7.42. And the median was 29.37.


HKSE:06929's PE Ratio (TTM) is ranked better than
86.75% of 400 companies
in the Medical Devices & Instruments industry
Industry Median: 29.7 vs HKSE:06929: 12.36

OrbusNeich Medical Group Holdings's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was HK$0.18. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.36.

As of today (2024-12-12), OrbusNeich Medical Group Holdings's share price is HK$4.50. OrbusNeich Medical Group Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.37. Therefore, OrbusNeich Medical Group Holdings's PE Ratio without NRI for today is 12.26.

During the past 5 years, OrbusNeich Medical Group Holdings's highest PE Ratio without NRI was 60.28. The lowest was 7.57. And the median was 27.07.

OrbusNeich Medical Group Holdings's EPS without NRI for the six months ended in Jun. 2024 was HK$0.18. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.37.

During the past 12 months, OrbusNeich Medical Group Holdings's average EPS without NRI Growth Rate was 11.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 91.60% per year.

During the past 5 years, OrbusNeich Medical Group Holdings's highest 3-Year average EPS without NRI Growth Rate was 91.60% per year. The lowest was 40.40% per year. And the median was 66.00% per year.

OrbusNeich Medical Group Holdings's EPS (Basic) for the six months ended in Jun. 2024 was HK$0.18. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.37.


OrbusNeich Medical Group Holdings PE Ratio (TTM) Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings PE Ratio (TTM) Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
N/A N/A N/A 44.22 16.67

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only At Loss 44.22 At Loss 16.67 At Loss

Competitive Comparison of OrbusNeich Medical Group Holdings's PE Ratio (TTM)

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's PE Ratio (TTM) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's PE Ratio (TTM) falls into.



OrbusNeich Medical Group Holdings PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

OrbusNeich Medical Group Holdings's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=4.50/0.364
=12.36

OrbusNeich Medical Group Holdings's Share Price of today is HK$4.50.
For company reported semi-annually, OrbusNeich Medical Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.36.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


OrbusNeich Medical Group Holdings  (HKSE:06929) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


OrbusNeich Medical Group Holdings PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.
Executives
Harmony Tree Limited 2101 Beneficial owner
Shenzhen Capital Group Co., Ltd. 2201 Interest of corporation controlled by you
Suzhou Red Earth Yeju Investment Ltd. 2101 Beneficial owner
Chien David 2201 Interest of corporation controlled by you
Lau Kwai Ching Denise 2201 Interest of corporation controlled by you
Shen Chuang Tou Zhi Zao Ye Zhuan Xing Sheng Ji Xin Cai Liao Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Shen Chuang Tou Hong Tu Si Mu Gu Quan Tou Zi Ji Jin Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Hong Tu Ye Ju Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you

OrbusNeich Medical Group Holdings Headlines

No Headlines